- Home
- Blogs
Belgian Federal Agency for Medicines and Health Products launches new medicines database
Browse this blog post
Related news and insights
Blog Post: 29 March 2023
Drug shortages: Belgian Royal Decree adopted which sets conditions for export authorisation
Blog Post: 08 March 2023
Blog Post: 28 November 2022
Blog Post: 02 August 2022
Compulsory licensing for expensive medicines – new report published in Belgium
The Federal Agency for Medicines and Health Products recently launched a new medicinal product database containing information on all medicinal products for human and veterinary use authorised in Belgium. This includes medicinal products that have a valid marketing authorisation, registration, authorisation for parallel import or temporary authorisation for use in Belgium.
The database includes a link to relevant documents such as the patient information leaflet, the summary of product characteristics, risk minimisation activities and the direct healthcare professional communication. It also lists information about the availability or temporary supply problems of medicinal products.
The new medicinal product database, which is available here, is more user-friendly than its previous version and is updated daily.